TrialDiabetes care2014

Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Lalitha Gudipaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.